RFC
AERI

Russell Frank Company’s Aerie Pharmaceuticals AERI Stock Holding History

Russell Frank Company’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-45,393
Closed -$1.42M – 3100
2015
Q1 		$1.42M Sell
45,393
-26,145
-37% -$758K ﹤0.01% 1965
2014
Q4 		$2.08M Buy
71,538
+4,250
+6% +$108K ﹤0.01% 1773
2014
Q3 		$1.39M Buy
67,288
+43,178
+179% +$851K ﹤0.01% 1913
2014
Q2 		$597K Buy
+24,110
New +$418K ﹤0.01% 2275

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Frank Company's AERI Position: Q2 2015 in Review

Russell Frank Company sold out of Aerie Pharmaceuticals (AERI) in Q2 2015, closing a stake of 45,393 shares — an estimated $1.42M sold.

Russell Frank Company first reported a position in AERI in Q2 2014 and held it in 4 quarters. The position peaked at $2.08M in Q4 2014. 108 funds tracked by Wall St. Rank hold AERI as of Q2 2015.

  • Russell Frank Company reported no remaining Aerie Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Russell Frank Company sold 45,393 Aerie Pharmaceuticals shares in Q2 2015, an estimated $1.42M.
  • Russell Frank Company first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Russell Frank Company's Aerie Pharmaceuticals position peaked at $2.08M in Q4 2014.
  • 108 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2015.

Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.